Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Yuskaitis, M.D., Ph.D.

Concepts (192)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Christopher Yuskaitis's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Christopher Yuskaitis has written about over time.
Glycogen Synthase Kinase 3, 6 publications between 2006 and 2010, average publication date March 2009. Lithium Chloride, 2 publications between 2008 and 2010, average publication date June 2009. Fragile X Syndrome, 3 publications between 2010 and 2010, average publication date April 2010. Fragile X Mental Retardation Protein, 5 publications between 2008 and 2013, average publication date August 2010. Dyslexia, 1 publications between 2015 and 2015, average publication date July 2015. Epilepsies, Partial, 1 publications between 2017 and 2017, average publication date December 2017. Malformations of Cortical Development, 1 publications between 2017 and 2017, average publication date December 2017. Seizures, 7 publications between 2008 and 2023, average publication date May 2019. GTPase-Activating Proteins, 4 publications between 2017 and 2022, average publication date September 2019. Neurons, 4 publications between 2017 and 2022, average publication date January 2020. Spasms, Infantile, 14 publications between 2013 and 2023, average publication date May 2020. Epilepsy, 9 publications between 2015 and 2023, average publication date October 2020. Anticonvulsants, 7 publications between 2019 and 2022, average publication date February 2021. Adrenocorticotropic Hormone, 3 publications between 2020 and 2022, average publication date May 2021. Vigabatrin, 3 publications between 2020 and 2022, average publication date May 2021. Convulsants, 1 publications between 2021 and 2021, average publication date June 2021. Pentylenetetrazole, 1 publications between 2021 and 2021, average publication date June 2021. Social Isolation, 1 publications between 2021 and 2021, average publication date June 2021. Fasting, 1 publications between 2022 and 2022, average publication date August 2022.

To see the data from this visualization as text, click here.
Yuskaitis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (192)
Explore
_
Co-Authors (46)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.